Introduction {#sec1_1}
============

Cerebrovascular ischemia can have a high impact on a patient\'s quality of life. It has a great burden of disease and is rated second on a disease-related mortality list in Europe \[[@B1]\] and fourth in the United States \[[@B2]\]. Of all strokes, 14-30% have a cardioembolic source \[[@B3]\], which is usually atrial fibrillation (AF) \[[@B4],[@B5]\]. AF is associated with a higher risk of ischemic cerebrovascular events and more severe ischemic strokes \[[@B5],[@B6],[@B7]\]. Treatment with anticoagulants is superior to treatment with antiplatelets, with a reduced risk of approximately 30% \[[@B5]\]. In the absence of a cardioembolic source, anticoagulants are not indicated. Therefore, it is important to detect or rule out AF as the cause of the stroke.

As described in international protocols, patients presenting with an ischemic cerebrovascular event undergo a 12-lead electrocardiogram (ECG) on admission and ECG monitoring for approximately 24-48 h. Not all patients with (paroxysmal) AF are detected during this period \[[@B8]\]. Nevertheless, it is not desirable to extensively evaluate every patient with regard to the cost-benefit ratio and patient burden. Decisions should be made on an individual basis by evaluating risk factors.

Several studies have been undertaken to explore the relation between specific stroke symptoms and the presence of AF as the cause of the stroke. These studies demonstrated a positive relation between aphasia and AF \[[@B4],[@B9],[@B10],[@B11],[@B12],[@B13]\]. In 15-30% of the patients, aphasia is present in the acute stage of stroke \[[@B11],[@B14]\]. Isolated aphasia has a lower incidence, yet exact numbers are unknown. Some studies have suggested a positive relation between isolated aphasia and AF \[[@B9],[@B15],[@B16]\]. However, these studies were performed with a small population sample \[[@B16]\], in a retrospective setting \[[@B9]\] or focused on a specific subtype of aphasia \[[@B15],[@B16]\].

The aim of the present observational study is to evaluate whether there is a relation between isolated aphasia and AF as the cause of cerebrovascular ischemia in a prospective setting.

Methods {#sec1_2}
=======

After approval by the local medical ethics committee, all patients admitted to the Atrium Medical Centre, Heerlen, the Netherlands, with cerebrovascular ischemia or a transient ischemic attack (TIA) in the period of August 2009 to March 2010 or October 2013 to January 2014 were included. Exclusion criteria were age \<18 years and intracranial pathology other than ischemia. No double inclusions were made; if a patient presented with a recurrent ischemic event, only the data of the first admission were used.

On admission, patients were evaluated by a neurologist. After history taking and examination, physical impairment was assessed with the National Institutes of Health Stroke Scale (NIHSS). A cranial computed tomography (CT) or magnetic resonance (MR) imaging was performed in all cases, and laboratory tests as well as an ECG were done. Thrombolysis was carried out if the patient met the criteria of our local stroke protocol (admission less than 4.5 h after stroke onset, NIHSS score \>2.5, absence of hemorrhage on CT and absence of other contraindications). All patients were admitted to our Brain Care Unit for 24-48 h with continuous ECG monitoring and blood pressure measurements at regular intervals. Treatment with aspirin was initiated, which was switched to clopidogrel after 2 weeks unless a cardioembolic source was identified.

Additional tests were done if indicated. An unknown localization of ischemia was assessed with MR imaging. Duplex carotid ultrasonography was performed if ischemia was located in the anterior cerebral circulation. A cardiologist evaluated ECG abnormalities and if AF was detected, antiplatelets were switched to oral anticoagulants.

Presence or absence of aphasia was evaluated on admission using bedside language examination. Comprehension, repetition and naming were tested according to the NIHSS. In case of TIA with complete recovery of language, a diagnosis was made based on the patients\' or, more often, their family\'s report. When possible, the ScreeLing Test and the Boston Naming Test were performed during hospitalization. Isolated aphasia was defined as any type of aphasia without other major deficits. Patients with only minor facial palsy or a drift of one extremity accompanying aphasia were included.

The medical histories of the patients were assessed. A history of TIA and/or ischemic cerebrovascular disease was noted as relevant neurological history. A history of angina pectoris, peripheral vascular disease, myocardial infarction, hypertension, AF and/or heart failure was referred to as relevant cardiovascular history. A relevant history of endocrine disease was assumed if hypercholesterolemia, type 2 diabetes and/or hypothyroidism were present.

The following variables were also recorded: left- or right-handedness, smoking, alcohol use, presence of familial cardiovascular disease, medication use (antiplatelet, anticoagulant, statin or antihypertensive drug), level of cholesterol, low-density lipoprotein, glucose and C-reactive protein, type of aphasia, presence of leukoariosis or recent ischemia on imaging, localization of ischemia, carotid stenosis/occlusion on ultrasound, MR or CT angiography, and finally whether carotid endarterectomy was performed.

At discharge, the Trial of Org 10172 in Acute Stroke Treatment (TOAST) classification was assigned. Furthermore, the patient\'s discharge destination (home or institution) was recorded. According to the TOAST classification, patients were divided into 4 groups. Group 1 included patients with ipsilateral internal carotid artery stenosis \>50% on ultrasound, CT or MR angiography. Group 2 included patients with cardioembolism as the most likely cause of the stroke. Patients were assigned to group 3 if they had a lacunar infarct and did not meet the criteria for group 1 or 2. Group 4 included patients with a cortical infarct who did not meet the criteria for group 1 or 2 or if they met the criteria for both groups.

Analyses were performed with IBM SPSS Statistics software 21, 2012. Pearson\'s χ^2^ test and Fisher\'s exact test were used for analyses of two categorical variables. The Mann-Whitney U test was used for the comparison of categorical variables with scale variables. Odds ratios (OR) and 95% confidence intervals (CI) were calculated using univariate and multivariate logistic regression analyses. For multivariate analyses, a univariate p = 0.15 was used. Significance was set at the p = 0.05 level.

Results {#sec1_3}
=======

Patient Characteristics {#sec2_1}
-----------------------

A total of 347 patients were included, of which 115 (33.1%) met the criteria for aphasia, with 26 (7.5%) meeting the criteria for isolated aphasia. Of all patients, 90 had a medical history of AF (66.7%) or AF was found during hospitalization (33.3%). Table [1](#T1){ref-type="table"} shows the baseline characteristics for patients with and without AF. Patients with AF used oral anticoagulants (34.4 vs. 4.7%, p \< 0.001) and antihypertensive drugs (83.3 vs. 62.6%, p \< 0.001) significantly more often than those without AF. 91.1% of the patients with AF had a relevant cardiovascular history in comparison to 67.3% of those without AF. Patients with AF were significantly older (p \< 0.001), but no significant difference was found in terms of gender. With reference to clinical presentation, patients with AF, compared to those without, presented more often with a cortical infarct (75.6 vs. 51.8%) and a NIHSS score \>9 (38.9 vs. 17.9%). Those with AF were less often discharged to their home (p \< 0.001) and more often referred to an institution (table [2](#T2){ref-type="table"}). No significant difference was found in the mortality rate during hospitalization (p = 0.139). Nine patients died from pneumonia, 6 from cerebral herniation, 2 from intracranial bleeding (one after thrombolysis and the other from hemorrhagic transformation), 2 from myocardial infarction and 1 from pulmonary hemorrhage.

Aphasia {#sec2_2}
-------

Patients with AF tended to present more often with any type of aphasia (41.1 vs. 30.4%) and isolated aphasia (10.0 vs. 6.6%); however, these differences were not significant. Nine patients with isolated aphasia had a history of AF or were found to have AF during admission. A significant relation was found between global aphasia and AF (p = 0.011). None of the patients were diagnosed with transcortical motor or transcortical sensory aphasia. Patients with AF scored significantly lower on the ScreeLing Test (61.5 vs. 64.7) and had a lower score for both aphasia tests together (p = 0.034). Only 123 patients finished both tests, but no significant differences between the tested and non-tested group regarding AF and isolated aphasia were noted. For the non-tested group, we noted the following reasons for non-testing: 45.2% went home before being tested, 8.9% could not speak/were mute, 4.9% were cognitively impaired, 2.9% had vision problems, 2.6% did not speak Dutch and 0.6% refused to be tested.

Table [3](#T3){ref-type="table"} presents the OR calculated for isolated aphasia and several patient characteristics. A history of TIA significantly increased the risk of isolated aphasia, and a history of AF also tended to increase the risk of isolated aphasia (OR 2.30, 95% CI 0.95-5.57), but this was not significant. After multivariate analyses, history of AF was adjusted for age, heart failure and history of TIA. When adjusted for history of heart failure, history of AF became significant (OR 3.13, CI 1.25-7.83).

In table [4](#T4){ref-type="table"}, OR were calculated for AF with several characteristics of aphasia. Global aphasia was significant in univariate analysis (OR 2.10, p = 0.012). When adjusted for the total ScreeLing Test score, significance was absent (p = 0.097).

Discussion {#sec1_4}
==========

Our study did not show a significant relation between isolated aphasia and AF. We demonstrated a tendency towards significance, but our hypothesis could not be proven. A history of AF tended to have a stronger relation with isolated aphasia than AF detected during admission. A positive relation between global aphasia and AF and a tendency towards significance for aphasia in general and AF were observed. With regard to the aphasia tests performed, patients with AF scored significantly lower on the ScreeLing Test alone and on both tests together.

In agreement with previous studies, patients with AF were more severely impaired, less often discharged to their home and older than patients without AF \[[@B9],[@B12]\]. The incidence of aphasia was similar to that reported in earlier studies, namely 33.1% in acute stage \[[@B10],[@B11],[@B13]\]. The incidence of AF (25.9%) was also comparable to other published data \[[@B3]\]. As in other studies, our results confirmed a significant relation between AF and the presence of a cortical infarct \[[@B10],[@B12]\].

In contrast to several other studies, our data did not show a significant relation between isolated aphasia and AF \[[@B9],[@B15],[@B16]\]. There are two possible explanations for this discrepancy. First, our results are based on a relatively small number of patients. If more patients with isolated aphasia had been be included, a potential significant relation might have been detected. Second, the group of patients with isolated aphasia included significantly more patients classified as TOAST 4. Of those patients, 13 did not have AF on ECG monitoring or an ipsilateral internal carotid artery stenosis/occlusion on ultrasound. It is possible that (paroxysmal) AF was not detected in those patients and that a more extensive follow-up might have demonstrated more patients with AF \[[@B17]\]. The relation between isolated aphasia and AF might have been underestimated. Contrary to the retrospective study of Fennis et al. \[[@B9]\], no significant relation was found between isolated aphasia and gender, type 2 diabetes and smoking in our study. Our small population sample could be accountable for this.

In several studies, such as that by Arboix et al. \[[@B18]\], in-hospital mortality was found to be significantly higher in stroke patients with AF compared to those without AF. In our study, however, no significant difference was found in mortality during hospitalization between the two groups (p = 0.139). This may be due to our small sample size or because of the difference in length of hospitalization.

In our study, 34.4% of all patients with AF were treated with anticoagulants prior to admission. This is different from the number found by Lamassa et al. \[[@B12]\], who noted a use of anticoagulants in only 8.4% of patients. The fact that we included patients with a relevant neurological history could explain this difference. A cardioembolic origin of stroke could already have been established and treated. More advanced diagnostics and better adherence to international guidelines in recent times could also have accounted for part of the difference.

In a previous study by Capmany et al. \[[@B19]\], the underlying structural heart disease causing cardioembolism was determined by performing color Doppler echocardiography in over 400 cardioembolic stroke patients. AF was found in 79.1% of these patients, but isolated AF accounted for only 21.9% of strokes. A common structural finding associated with AF was hypertensive left ventricular hypertrophy. In our study, however, transesophageal echocardiography was not routinely used in all patients, since two-thirds of the AF patients had already been diagnosed with AF before having had an ischemic stroke. Therefore, we were unable to reliably distinguish between isolated AF or AF combined with another underlying potential source of cardioembolism \[[@B19]\].

Our study has some limitations. As mentioned above, our results are based on a relatively small sample size. Wide 95% confidence intervals were present, and multivariate analyses could only be performed with three variables. Therefore, our results should be interpreted with caution. Another focus of attention is that only 34.9% of the patients completed both aphasia tests. Despite the fact that no significant differences were found regarding AF and isolated aphasia between the tested and non-tested group, results would be more reliable if a higher percentage of patients had been tested. Most of the missing patients were not tested because they went home or to a rehabilitation center before finishing the tests. In general, patients were admitted for a short period of time during which several additional diagnostics were performed. Hence, the lack of time was the most important reason patients went home before being fully tested.

In conclusion, this prospective observational study could not prove the hypothesis that isolated aphasia is related to cardioembolic stroke. Our results show a tendency towards significance but a larger sample size is needed. More prospective studies should be performed before a definite relation can be confirmed. Nonetheless, a cardioembolic source should be thoroughly evaluated when a patient presents with isolated aphasia without an evident cause.
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###### 

Patient characteristics

  Variables                               All (n = 347)       AF (n = 90)[^1^](#T1F1){ref-type="table-fn"}   No AF (n = 257)     p
  --------------------------------------- ------------------- ---------------------------------------------- ------------------- ---------
  *Patient characteristics*                                                                                                      
  Mean age, years                         73.5 (20.0--98.9)   79.6 (48.4--98.9)                              71.4 (20.0--95.3)   \<0.001
  Male sex                                150 (43.2)          33 (36.7)                                      117 (45.5)          0.114
  Handedness                                                                                                                     
   Right dominance                        216 (62.2)          45 (50.0)                                      171 (66.5)          0.410
   Left dominance                         21 (6.1)            6 (6.7)                                        15 (5.8)            0.410
   Unknown                                110 (31.7)          39 (43.3)                                      71 (27.6)           0.006
  Relevant neurological history           98 (28.2)           31 (34.4)                                      67 (26.1)           0.129
  Relevant cardiovascular history         255 (73.5)          82 (91.1)                                      173 (67.3)          \<0.001
  Relevant history of endocrine disease   132 (38.0)          36 (40.0)                                      95 (37.4)           0.656
  Smoking                                                                                                                        
   Yes                                    92 (26.5)           16 (17.8)                                      76 (29.6)           0.065
   No                                     236 (68.0)          64 (71.1)                                      172 (66.9)          0.065
   Unknown                                19 (5.5)            10 (11.1)                                      9 (3.5)             0.006
  Alcohol use \>1 drink/day               33 (9.5)            6 (6.7)                                        27 (10.5)           0.383
  Positive family history for CVD         100 (28.8)          21 (23.3)                                      79 (30.7)           0.766
                                                                                                                                 
  *Medication*                                                                                                                   
  Platelet aggregation inhibitor          158 (45.5)          42 (46.7)                                      116 (45.1)          0.802
  Oral anticoagulant                      43 (12.4)           31 (34.4)                                      12 (4.7)            \<0.001
  Statin                                  127 (36.6)          37 (41.1)                                      90 (35.0)           0.302
  Antihypertensive drug                   236 (68.0)          75 (83.3)                                      160 (62.6)          \<0.001
                                                                                                                                 
  *Laboratory testing*                                                                                                           
  Cholesterol level, mmol/l               4.5 (2.0--9.0)      4.4 (2.0--7.8)                                 4.6 (2.2--9.0)      0.328
  LDL level, mmol/l                       2.7 (0.6--6.9)      2.6 (0.9--5.3)                                 2.7 (0.6--6.9)      0.290

Values represent n (%) or mean (range). CVD = Cardiovascular disease; LDL = low-density lipoprotein.

AF history or during admission.

###### 

Clinical presentation

  Variables                                 All (n = 347)     AF (n = 90)[^1^](#T2F1){ref-type="table-fn"}   No AF (n = 257)   p
  ----------------------------------------- ----------------- ---------------------------------------------- ----------------- ---------
  Thrombolysis                              57 (16.4)         17 (18.9)                                      40 (15.6)         0.464
  NIHSS score \>9                           81 (23.3)         35 (38.9)                                      46 (17.9)         \<0.001
  CT/MR imaging (acute cerebral infarct)    87 (25.1)         22 (24.4)                                      65 (25.3)         0.873
  Infarct location                                                                                                             
   Cortical                                 201 (57.9)        68 (75.6)                                      133 (51.8)        \<0.001
  Lacunar                                   144 (41.5)        21 (23.3)                                      123 (47.9)        \<0.001
  Duplex (ipsilateral occlusion/stenosis)   47 (13.5)         8 (8.9)                                        39 (15.2)         0.252
  Deceased                                  20 (5.8)          8 (8.9)                                        12 (4.7)          0.139
  Discharged home                           189 (54.5)        33 (36.7)                                      156 (60.7)        \<0.001
  Aphasia                                                                                                                      
   Aphasia                                  115 (33.1)        37 (41.1)                                      78 (30.4)         0.062
   Isolated aphasia                         26 (7.5)          9 (10.0)                                       17 (6.6)          0.294
   Global aphasia                           65 (18.7)         25 (27.8)                                      40 (15.6)         0.011
   Wernicke\'s aphasia                      3 (0.9)           1 (1.1)                                        2 (0.8)           1.000
   Broca\'s aphasia                         47 (13.5)         11 (12.2)                                      36 (14.0)         0.670
   Total ScreeLing score                    64.0 (19--72)     61.5 (38--71)                                  64.7 (19--72)     0.042
   Total Boston Naming Test score           148.6 (11--180)   141.7 (63--177)                                150.5 (11--180)   0.059
  Boston Naming Test + ScreeLing score      212.6 (43--252)   203.2 (105--246)                               215.2 (43--252)   0.034

Values represent n (%) or mean (range).

AF history or during admission.

###### 

Relationship of isolated aphasia with several characteristics

  Variables (number of patients)              Isolated aphasia (n = 26)[^1^](#T3F1){ref-type="table-fn"}   p
  ------------------------------------------- ------------------------------------------------------------ -------
  *Univariate*                                                                                             
  Age                                         1.03 (0.99--1.07)                                            0.122
  Male sex (14)                               1.59 (0.71--3.54)                                            0.259
  History of AF (8)                           2.30 (0.95--5.57)                                            0.065
  AF during admission (3)                     0.56 (0.16--1.91)                                            0.351
  History of heart failure (1)                0.22 (0.03--1.68)                                            0.145
  History of TIA (8)                          2.66 (1.09--6.47)                                            0.031
  History of CVA (3)                          0.59 (0.17--2.04)                                            0.405
  Type 2 diabetes (4)                         0.68 (0.23--2.03)                                            0.486
  Smoking (4)                                 0.47 (0.16--1.40)                                            0.172
  Positive family history for CVD (8)         1.10 (0.43--2.80)                                            0.839
  Total ScreeLing score (10)                  1.00 (0.93--1.08)                                            0.955
  Total Boston Naming Test score (10)         1.01 (0.98--1.04)                                            0.448
  Boston Naming Test + ScreeLing score (10)   1.01 (0.99--1.03)                                            0.523
  TOAST 1 (3)                                 1.06 (0.30--3.72)                                            0.925
  TOAST 2 (8)                                 1.45 (0.61--3.47)                                            0.402
  TOAST 4 (15)                                2.46 (1.10--5.54)                                            0.029
  Discharged home (24)                        11.35 (2.64--48.8)                                           0.001
                                                                                                           
  *Multivariate*                                                                                           
  History of AF, adjusted for                                                                              
   Age                                        1.96 (0.79--4.92)                                            0.149
   History of TIA                             2.29 (0.94--5.60)                                            0.068
   History of heart failure                   3.13 (1.25--7.83)                                            0.015
   Age + history of TIA                       2.01 (0.80--5.06)                                            0.138
   Age + history of heart failure             2.64 (1.03--6.77)                                            0.043
   TIA + history of heart failure             3.11 (1.23--7.86)                                            0.016

CVA = Cerebrovascular accident; CVD = cardiovascular disease.

Values represent OR (95% CI).

###### 

Relationship of AF with several characteristics of aphasia

  Variables (number of patients)                       AF (n = 90)[^1^](#T4F1){ref-type="table-fn"}   p
  ---------------------------------------------------- ---------------------------------------------- -------
  *Univariate*                                                                                        
  Aphasia (37)                                         1.60 (0.98--2.63)                              0.063
  Isolated aphasia (9)                                 1.57 (0.67--3.70)                              0.297
  Global aphasia (25)                                  2.10 (1.18--3.70)                              0.012
  Wernicke\'s aphasia (1)                              1.43 (0.13--16.00)                             0.770
  Broca\'s aphasia (11)                                0.86 (0.42--1.76)                              0.670
  Total ScreeLing score                                0.97 (0.92--1.01)                              0.110
  Total Boston Naming Test score                       0.99 (0.98--1.01)                              0.216
  Total Boston Naming Test + ScreeLing score           0.99 (0.98--1.00)                              0.167
                                                                                                      
  *Multivariate*                                                                                      
  Global aphasia, adjusted for Total ScreeLing score   2.64 (0.84--8.33)                              0.097

Values represent OR (95% CI).
